The Food and Drug Administration has given the regulatory greenlight to IDX Systems for its IDXview image management product.IDXview represents the Burlington, VT, company's effort to expandfrom its base in radiology information systems into digital
The Food and Drug Administration has given the regulatory greenlight to IDX Systems for its IDXview image management product.IDXview represents the Burlington, VT, company's effort to expandfrom its base in radiology information systems into digital imagemanagement, according to Britt Cummings, manager of radiologysystems.
IDXview is based on Digital Equipment Alpha workstation architecturerunning an X-Windows operating system with 1k x 1k display monitors.It is DICOM-compliant and can be integrated with the company'sIDXrad RIS product, making it one of the first commercially availableintegrated RIS/image management solutions.
IDXview is not a PACS product, Cummings said, because it lacksthe 2k x 2k monitor technology required for primary diagnosis.Instead, IDX will market the system as ideal for consultationand review between radiology departments and referring physiciansin other areas. A primary diagnosis component can be added vialinks to PACS products from other vendors, he said.
IDX will emphasize the integrated nature of the RIS and imagemanagement system in marketing IDXview. IDXrad has a sophisticatedsearch engine that makes it easy for physicians to locate andsort patient data, according to Cummings.
"Because we are so tied to the RIS, we have some verysimple and efficient searches to find the patient (physicians)are looking for," Cummings said.
There are two beta sites using IDXview and the company is readyto begin shipping the product.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.